The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 20 Jul 2004
doi: 10.1242/jcs.01246
Research Article
Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells
Hisami Takenouchi,
Nobutaka Kiyokawa*,
Tomoko Taguchi,
Jun Matsui,
Yohko U. Katagiri,
Hajime Okita,
Kenji Okuda,
and
Junichiro Fujimoto
* Author for correspondence (e-mail: nkiyokawa{at}nch.go.jp)
Shiga toxin is a bacterial toxin consisting of A and B subunits. Generally, the essential cytotoxicity of the toxin is thought to be mediated by the A subunit, which possesses RNA cleavage activity and thus induces protein synthesis inhibition. We previously reported, however, that the binding of the Shiga toxin 1-B subunit to globotriaosyl ceramide, a functional receptor for Shiga toxin, induces intracellular signals in a manner that is dependent on glycolipid-enriched membrane domains, or lipid rafts. Although the precise role of this signaling mechanism is not known, here we report that Shiga-toxin-mediated intracellular signals induce cytoskeleton remodeling in ACHN cells derived from renal tubular epithelial carcinoma. Using confocal laser scanning microscopy, we observed that Shiga toxin 1-B treatment induces morphological changes in ACHN cells in a time-dependent manner. In addition, the morphological changes were accompanied by the redistribution of a number of proteins, including actin, ezrin, CD44, vimentin, cytokeratin, paxillin, FAK, and
- and
-tubulins, all of which are involved in cytoskeletal organization. The transient phosphorylation of ezrin and paxillin was also observed during the course of protein redistribution. Experiments using inhibitors for a variety of kinases suggested the involvement of lipid rafts, Src family protein kinase, PI 3-kinase, and RHO-associated kinase in Shiga toxin 1-B-induced ezrin phosphorylation. Shiga toxin 1-B-induced cytoskeletal remodeling should provide an in vitro model that can be used to increase our understanding of the pathogenesis of Shiga-toxin-mediated cell injury and the role of lipid-raft-mediated cell signaling in cytoskeletal remodeling.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Hehnly, K. M. Longhini, J.-L. Chen, and M. Stamnes
Retrograde Shiga Toxin Trafficking Is Regulated by ARHGAP21 and Cdc42
Mol. Biol. Cell,
October 15, 2009;
20(20):
4303 - 4312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Walchli, S. S. Skanland, T. F. Gregers, S. U. Lauvrak, M. L. Torgersen, M. Ying, S. Kuroda, A. Maturana, and K. Sandvig
The Mitogen-activated Protein Kinase p38 Links Shiga Toxin-dependent Signaling and Trafficking
Mol. Biol. Cell,
January 1, 2008;
19(1):
95 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Torgersen, S. Walchli, S. Grimmer, S. S. Skanland, and K. Sandvig
Protein Kinase C{delta} Is Activated by Shiga Toxin and Regulates Its Transport
J. Biol. Chem.,
June 1, 2007;
282(22):
16317 - 16328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Gyles
Shiga toxin-producing Escherichia coli: An overview
J Anim Sci,
March 1, 2007;
85(13_suppl):
E45 - E62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja
Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling
Am. J. Pathol.,
December 1, 2006;
169(6):
1965 - 1975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hehnly, D. Sheff, and M. Stamnes
Shiga Toxin Facilitates Its Retrograde Transport by Modifying Microtubule Dynamics
Mol. Biol. Cell,
October 1, 2006;
17(10):
4379 - 4389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Nolasco, N. A. Turner, A. Bernardo, Z. Tao, T. G. Cleary, J.-f. Dong, and J. L. Moake
Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers
Blood,
December 15, 2005;
106(13):
4199 - 4209.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2004